FARMEXIM S.A. secures contract for Antineoplastic and Immunomodulating Agents- Framing Frameal Agreement in the "antineoplastic and immunomodulatory" group- 2 lots- trastuzumab Deruxtecan 100 mg, Eribulinum 044 mg/ml, 2 ml

Romania, May 16 -- Romania based FARMEXIM S.A. has secured contract from Operator SEAP for Antineoplastic and Immunomodulating Agents- Framing Frameal Agreement in the "antineoplastic and immunomodulatory" group- 2 lots- trastuzumab Deruxtecan 100 mg, Eribulinum 044 mg/ml, 2 ml. The value of the contract is worth 22326270 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....